Related Experiment Video
Updated: Jul 2, 2025
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Published on: January 20, 2023
The mRNA-LNP vaccines - the good, the bad and the ugly?
1Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, United States.
Insights
Messenger RNA (mRNA) vaccines, utilizing lipid nanoparticle (LNP) delivery, showed early promise for COVID-19. However, recent data raise significant safety and efficacy concerns requiring further investigation.
Area of Science:
- Vaccinology
- Immunology
- Biotechnology
Background:
- The COVID-19 pandemic highlighted the rapid development and deployment of mRNA-LNP vaccines.
- Initial clinical trials suggested broad safety and effectiveness across diverse populations.
Approach:
- This review synthesizes current data on mRNA-LNP vaccine safety and efficacy.
- It explores potential mechanisms underlying observed adverse events.
Key Points:
- Emerging data indicate potential safety and effectiveness concerns with mRNA-LNP vaccines.
- The review examines specific adverse events and their potential biological underpinnings.
Conclusions:
- Further research is needed to address safety and efficacy issues.
- Potential mitigation strategies for vaccine-related adverse events are discussed.
Abstract:
The mRNA-LNP vaccine has received much attention during the COVID-19 pandemic since it served as the basis of the most widely used SARS-CoV-2 vaccines in Western countries. Based on early clinical trial data, these vaccines were deemed safe and effective for all demographics. However, the latest data raise serious concerns about the safety and effectiveness of these vaccines. Here, we review some of the safety and efficacy concerns identified to date. We also discuss the potential mechanism of observed adverse events related to the use of these vaccines and whether they can be mitigated by alterations of this vaccine mechanism approach.
More Related Videos
08:54Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector
Published on: May 30, 2025
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
